Nkarta (NKTX) Amortizatization of Intangibles (2020 - 2026)
Nkarta's (NKTX) quarterly Amortizatization of Intangibles came in at $753000.0 in Q1 2026, down 51.88% year-on-year from $1.6 million in Q1 2025, and down 11.93% quarter-over-quarter from $855000.0 in Q4 2025.
Nkarta (NKTX) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Nkarta's Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $753000.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 51.88% year-over-year to $753000.0 in Q1 2026; TTM through Mar 2026 was $3.8 million, a 45.46% decrease from a year earlier, with the FY2025 full-year figure at $4.6 million, down 33.74% from the prior year.
- Amortizatization of Intangibles declined to $753000.0 in Q1 2026 per NKTX's latest filing, from $855000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.4 million in Q3 2023 and bottomed at -$727000.0 in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $1.6 million (2025), against an average of $1.3 million.
- Across the five-year window, Amortizatization of Intangibles jumped 689.56% in 2023 and tumbled 55.79% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $1.6 million in 2022, then advanced by 28.08% to $2.0 million in 2023, then dropped by 4.49% to $1.9 million in 2024, then sank by 55.79% to $855000.0 in 2025, then retreated by 11.93% to $753000.0 in 2026.
- Per Business Quant, the three latest NKTX Amortizatization of Intangibles figures stand at $753000.0 (Q1 2026), $855000.0 (Q4 2025), and $953000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Nkarta | 168.94 Mn | 168.94 Mn | - | 753,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 753,000.00 |
| Mar 31, 2026 | 753,000.00 |
| Dec 31, 2025 | 855,000.00 |
| Dec 31, 2025 | 855,000.00 |
| Sep 30, 2025 | 953,000.00 |
| Sep 30, 2025 | 953,000.00 |
| Jun 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.57 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 2.03 Mn |
| Dec 31, 2023 | 2.03 Mn |